144 related articles for article (PubMed ID: 21810523)
1. Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Broy SB; Tanner SB;
J Clin Densitom; 2011; 14(3):184-9. PubMed ID: 21810523
[TBL] [Abstract][Full Text] [Related]
2. Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®).
Leib ES; Saag KG; Adachi JD; Geusens PP; Binkley N; McCloskey EV; Hans DB;
J Clin Densitom; 2011; 14(3):212-9. PubMed ID: 21810527
[TBL] [Abstract][Full Text] [Related]
3. Official Positions for FRAX® clinical regarding prior fractures from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Blank RD;
J Clin Densitom; 2011; 14(3):205-11. PubMed ID: 21810526
[TBL] [Abstract][Full Text] [Related]
4. Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Lewiecki EM; Compston JE; Miller PD; Adachi JD; Adams JE; Leslie WD; Kanis JA; Moayyeri A; Adler RA; Hans DB; Kendler DL; Diez-Perez A; Krieg MA; Masri BK; Lorenc RR; Bauer DC; Blake GM; Josse RG; Clark P; Khan AA;
J Clin Densitom; 2011; 14(3):226-36. PubMed ID: 21810530
[TBL] [Abstract][Full Text] [Related]
5. FRAX(®) Clinical Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.
McCloskey EV; Binkley N;
J Clin Densitom; 2011; 14(3):181-3. PubMed ID: 21810522
[TBL] [Abstract][Full Text] [Related]
6. Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Masud T; Binkley N; Boonen S; Hannan MT;
J Clin Densitom; 2011; 14(3):194-204. PubMed ID: 21810525
[TBL] [Abstract][Full Text] [Related]
7. Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Cauley JA; El-Hajj Fuleihan G; Arabi A; Fujiwara S; Ragi-Eis S; Calderon A; Chionh SB; Chen Z; Curtis JR; Danielson ME; Hanley DA; Kroger H; Kung AW; Lesnyak O; Nieves J; Pluskiewicz W; El Rassi R; Silverman S; Schott AM; Rizzoli R; Luckey M;
J Clin Densitom; 2011; 14(3):240-62. PubMed ID: 21810532
[TBL] [Abstract][Full Text] [Related]
8. FRAX(®) Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.
Lewiecki EM; Compston JE; Miller PD; Adachi JD; Adams JE; Leslie WD; Kanis JA;
J Clin Densitom; 2011; 14(3):223-5. PubMed ID: 21810529
[TBL] [Abstract][Full Text] [Related]
9. Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
Dimai HP; Chandran M;
J Clin Densitom; 2011; 14(3):190-3. PubMed ID: 21810524
[TBL] [Abstract][Full Text] [Related]
10. Medications associated with fracture risk in patients with rheumatoid arthritis.
Ozen G; Pedro S; Wolfe F; Michaud K
Ann Rheum Dis; 2019 Aug; 78(8):1041-1047. PubMed ID: 31092411
[TBL] [Abstract][Full Text] [Related]
11. Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.
McCloskey EV; Vasikaran S; Cooper C;
J Clin Densitom; 2011; 14(3):220-2. PubMed ID: 21810528
[TBL] [Abstract][Full Text] [Related]
12. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
13. FRAX 10-yr Fracture Risk in Rheumatoid Arthritis-Assessments With and Without Bone Mineral Density May Lead to Very Different Results in the Individual Patient.
Elde KD; Madsen OR
J Clin Densitom; 2019; 22(1):31-38. PubMed ID: 30497868
[TBL] [Abstract][Full Text] [Related]
14. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
Hans DB; Kanis JA; Baim S; Bilezikian JP; Binkley N; Cauley JA; Compston JE; Cooper C; Dawson-Hughes B; El-Hajj Fuleihan G; Leslie WD; Lewiecki EM; Luckey MM; McCloskey EV; Papapoulos SE; Poiana C; Rizzoli R;
J Clin Densitom; 2011; 14(3):171-80. PubMed ID: 21810521
[TBL] [Abstract][Full Text] [Related]
15. FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.
Cauley JA; El-Hajj Fuleihan G; Luckey MM;
J Clin Densitom; 2011; 14(3):237-9. PubMed ID: 21810531
[TBL] [Abstract][Full Text] [Related]
16. Management of osteoporosis in rheumatoid arthritis patients.
Hoes JN; Bultink IE; Lems WF
Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
[TBL] [Abstract][Full Text] [Related]
18. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
Phuan-Udom R; Lektrakul N; Katchamart W
Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
[TBL] [Abstract][Full Text] [Related]
19. [Comparison fracture risk calculated by FRAX tool].
Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
[TBL] [Abstract][Full Text] [Related]
20. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis.
Kim D; Cho SK; Kim JY; Choi YY; Sung YK
Mod Rheumatol; 2016 Jul; 26(4):540-5. PubMed ID: 26418481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
